014570 — Korean Drug Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro CapContrarian

Annual balance sheet for Korean Drug Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11,526	22,230	27,881	26,416	16,756
Net Total Accounts Receivable
Net Total Receivables	28,080	27,894	28,983	31,460	28,008
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	51,535	62,956	70,450	72,617	63,426
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	14,849	13,784	13,999	18,607	22,999
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	75,850	83,345	88,613	94,516	89,709
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	6,523	9,771	10,329	7,412	9,902
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	10,800	12,474	11,923	9,804	12,619
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	65,050	70,871	76,690	84,713	77,090
Total Liabilities & Shareholders' Equity	75,850	83,345	88,613	94,516	89,709
Total Common Shares Outstanding